Crossmark Global Holdings’s Ascendis Pharma ASND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$927K	Sell	5,368 -480	-8%	-$82.8K	0.02%	644
2025 Q1	$911K	Sell	5,848 -4,587	-44%	-$715K	0.02%	644
2024 Q4	$1.44M	Buy	10,435 +2,315	+29%	+$319K	0.03%	479
2024 Q3	$1.21M	Buy	+8,120	New	+$1.21M	0.02%	544